Gilead Sciences, Inc. (GILD) Financials

GILD Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 49.4 billion 37.6 billion
March 31, 2026 56.3 billion 32.8 billion
Dec. 31, 2025 59.0 billion 36.4 billion
Sept. 30, 2025 58.5 billion 37.1 billion

GILD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 3.7 billion -218.0 million
March 31, 2026 2.4 billion 218.0 million
Dec. 31, 2025 3.1 billion 230.0 million
Sept. 30, 2025 4.0 billion 230.0 million

GILD Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -2.0 billion
March 31, 2026 2.0 billion
Dec. 31, 2025 2.2 billion
Sept. 30, 2025 3.1 billion

GILD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.2 billion - -
March 31, 2026 7.6 billion 20.9 billion -
Dec. 31, 2025 9.6 billion 22.1 billion -
Sept. 30, 2025 7.3 billion 22.1 billion -

GILD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 1.2 billion
March 31, 2026 1.3 billion
Dec. 31, 2025 1.3 billion
Sept. 30, 2025 1.3 billion

GILD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 117.0 million 1.8 billion 1.9 billion -
March 31, 2026 117.0 million 1.4 billion 1.5 billion 898.0 million
Dec. 31, 2025 205.0 million 1.6 billion 1.7 billion 1.1 billion
Sept. 30, 2025 147.0 million 1.3 billion 1.4 billion 829.0 million

GILD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 7.8 billion 1.6 billion
March 31, 2026 7.0 billion 1.4 billion
Dec. 31, 2025 7.9 billion 1.6 billion
Sept. 30, 2025 7.8 billion 1.6 billion

GILD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

GILD

Price: $146.74

52 week price:
106.44
157.29

Dividend Yield: 2.42%

5-year range yield:
2.14%
5.18%

Forward Dividend Yield: 2.24%

Payout Ratio: 375.61%

Payout Ratio Range:
-69.01%
24533.33%

Dividend Per Share: 3.28 USD

Earnings Per Share: -2.65 USD

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 2.7 million

Ebitda: 2.4 billion

Market Capitalization: 165.0 billion

Average Dividend Frequency: 4

Years Paying Dividends: 12

DGR3: 2.70%

DGR5: 3.56%

DGR10: 30.00%

Links: